Wen Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wen Zhong has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Chang Liu
School of Sport Science, Beijing Sport University, Beijing 100084, China
4 shared publications - Shuning Liu
School of Sport Science, Beijing Sport University, Beijing 100084, China
4 shared publications - Kai Zhao
China Volleyball Academy, Beijing Sport University, Beijing 100084, China
3 shared publications - Samuhaer Azhati
School of Education, Beijing Sport University, Beijing, China
3 shared publications - Yan Wei
School of Education, Beijing Sport University, Beijing 100084, China
3 shared publications - Wei Jiang
China Volleyball Academy, Beijing Sport University, Beijing 100084, China
2 shared publications
Latest Publications
- 24 September 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16
The effects of coenzyme Q10 supplementation on exercise-induced oxidative stress and related physiological outcomes in athletes: a systematic review and meta-analysis
Exercise-induced oxidative stress has been proposed as a mechanistic link between heavy training loads, membrane injury, impaired recovery, and inconsistent performance responses. Coenzyme Q10 (CoQ10), a mitochondrial electron-transport cofactor and lipid-phase antioxidant, is therefore widely promoted as a supportive supplement for athletes, although randomized evidence remains inconsistent. We systematically searched PubMed, Web of Science, Embase, and EBSCOhost from database inception to April 2026 and prospectively registered the review in PROSPERO (CRD420261370320). Randomized parallel-group and crossover trials evaluating oral CoQ10 in athletes or athlete-relevant trained individuals were eligible. Twenty-four studies (613 participants) were included in the systematic review, and 15 studies (330 participants) contributed to at least one quantitative synthesis. Because several studies contributed more than one eligible estimate, the unit of quantitative reporting was the effect size/comparison. Random-effects models were used for meta-analysis. Overall risk of bias was judged as some concerns in 23 of 24 studies (95.8%) and high risk in one study (4.2%). The primary pooled analysis for malondialdehyde (MDA) included seven effect sizes/comparisons from five studies and was not statistically significant (SMD = -0.96, 95% CI -2.07 to 0.15; I² = 73.0%). In the sensitivity analysis, the pooled MDA effect favored CoQ10 (SMD = -0.93, 95% CI -1.65 to -0.22; I² = 73.0%), but this signal remained fragile. The representative pooled physiological outcome, VO₂max, included eight effect sizes/comparisons from seven studies and was neutral (SMD = 0.03, 95% CI -0.32 to 0.39; I² = 0.0%). Supplementary pooled analyses were likewise neutral for blood pressure, creatine kinase, interleukin-6, total antioxidant capacity, tumor necrosis factor-α, and anaerobic threshold. Narrative synthesis, however, suggested more coherent context-dependent signals in studies conducted under marked oxidative or recovery stress. Current evidence does not support a robust overall ergogenic or physiological benefit of CoQ10 supplementation in athletes. The only potentially favorable quantitative signal emerged in the MDA sensitivity analysis; however, this finding should be interpreted cautiously because of residual heterogeneity, small sample sizes, and methodological limitations.
- 24 September 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16
The effects of coenzyme Q10 supplementation on exercise-induced oxidative stress and related physiological outcomes in athletes: a systematic review and meta-analysis
Exercise-induced oxidative stress has been proposed as a mechanistic link between heavy training loads, membrane injury, impaired recovery, and inconsistent performance responses. Coenzyme Q10 (CoQ10), a mitochondrial electron-transport cofactor and lipid-phase antioxidant, is therefore widely promoted as a supportive supplement for athletes, although randomized evidence remains inconsistent. We systematically searched PubMed, Web of Science, Embase, and EBSCOhost from database inception to April 2026 and prospectively registered the review in PROSPERO (CRD420261370320). Randomized parallel-group and crossover trials evaluating oral CoQ10 in athletes or athlete-relevant trained individuals were eligible. Twenty-four studies (613 participants) were included in the systematic review, and 15 studies (330 participants) contributed to at least one quantitative synthesis. Because several studies contributed more than one eligible estimate, the unit of quantitative reporting was the effect size/comparison. Random-effects models were used for meta-analysis. Overall risk of bias was judged as some concerns in 23 of 24 studies (95.8%) and high risk in one study (4.2%). The primary pooled analysis for malondialdehyde (MDA) included seven effect sizes/comparisons from five studies and was not statistically significant (SMD = -0.96, 95% CI -2.07 to 0.15; I² = 73.0%). In the sensitivity analysis, the pooled MDA effect favored CoQ10 (SMD = -0.93, 95% CI -1.65 to -0.22; I² = 73.0%), but this signal remained fragile. The representative pooled physiological outcome, VO₂max, included eight effect sizes/comparisons from seven studies and was neutral (SMD = 0.03, 95% CI -0.32 to 0.39; I² = 0.0%). Supplementary pooled analyses were likewise neutral for blood pressure, creatine kinase, interleukin-6, total antioxidant capacity, tumor necrosis factor-α, and anaerobic threshold. Narrative synthesis, however, suggested more coherent context-dependent signals in studies conducted under marked oxidative or recovery stress. Current evidence does not support a robust overall ergogenic or physiological benefit of CoQ10 supplementation in athletes. The only potentially favorable quantitative signal emerged in the MDA sensitivity analysis; however, this finding should be interpreted cautiously because of residual heterogeneity, small sample sizes, and methodological limitations.
- 12 September 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (10) , 424
Syringaresinol activates the skeletal muscle SIRT1–FNDC5/irisin axis to enhance weight management
This study examined whether syringaresinol (SYR), a plant-derived lignan, modulates skeletal muscle SIRT1-related FNDC5/Irisin signaling and high-fat diet (HFD)-associated metabolic outcomes. Differentiated C2C12 myotubes were treated with SYR, the SIRT1 activator SRT1720, and the SIRT1 inhibitor EX-527 to assess Irisin-related readouts, mitochondrial-associated markers, gene expression, and SIRT1/PGC-1α protein abundance. In vivo, HFD-fed mice received low- or high-dose SYR by oral gavage for 18 weeks; body weight, food intake, plasma Irisin, lipid-related indices, and adipose-tissue gene expression were assessed. In C2C12 myotubes, SYR was associated with increased Irisin-related readouts, ATP content, citrate synthase activity, SIRT1/PGC-1α/FNDC5-related transcriptional changes, and higher SIRT1 and PGC-1α protein abundance. EX-527 attenuated SYR-associated responses, supporting involvement of SIRT1 signaling in the cellular model. In HFD-fed mice, SYR attenuated body-weight gain, increased circulating plasma Irisin, lowered the LDL-C/HDL-C ratio, and increased PGC-1α, Ucp1, and Pparγ expression in inguinal white adipose tissue without significantly changing food intake. SYR is associated with SIRT1/PGC-1α-related remodeling, Irisin-related readouts, and attenuated HFD-induced weight gain. These findings support SYR as a candidate nutritional modulator of muscle–adipose metabolic communication, while causal in vivo mediation by SIRT1, FNDC5, or Irisin requires further pathway-specific validation.
- 12 September 2026
- Published by Springer Nature in 3 Biotech
- Vol. 16 (10) , 424
Syringaresinol activates the skeletal muscle SIRT1–FNDC5/irisin axis to enhance weight management
This study examined whether syringaresinol (SYR), a plant-derived lignan, modulates skeletal muscle SIRT1-related FNDC5/Irisin signaling and high-fat diet (HFD)-associated metabolic outcomes. Differentiated C2C12 myotubes were treated with SYR, the SIRT1 activator SRT1720, and the SIRT1 inhibitor EX-527 to assess Irisin-related readouts, mitochondrial-associated markers, gene expression, and SIRT1/PGC-1α protein abundance. In vivo, HFD-fed mice received low- or high-dose SYR by oral gavage for 18 weeks; body weight, food intake, plasma Irisin, lipid-related indices, and adipose-tissue gene expression were assessed. In C2C12 myotubes, SYR was associated with increased Irisin-related readouts, ATP content, citrate synthase activity, SIRT1/PGC-1α/FNDC5-related transcriptional changes, and higher SIRT1 and PGC-1α protein abundance. EX-527 attenuated SYR-associated responses, supporting involvement of SIRT1 signaling in the cellular model. In HFD-fed mice, SYR attenuated body-weight gain, increased circulating plasma Irisin, lowered the LDL-C/HDL-C ratio, and increased PGC-1α, Ucp1, and Pparγ expression in inguinal white adipose tissue without significantly changing food intake. SYR is associated with SIRT1/PGC-1α-related remodeling, Irisin-related readouts, and attenuated HFD-induced weight gain. These findings support SYR as a candidate nutritional modulator of muscle–adipose metabolic communication, while causal in vivo mediation by SIRT1, FNDC5, or Irisin requires further pathway-specific validation.
- Open Access
- 29 May 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (6) , 370
Acute Capillary Plasma Biomarker, Neuromuscular, and Perceptual Responses to Standardised Soccer Match Play in Elite Players: A Descriptive Study of Asynchronous Multi-Domain Recovery
Background: Soccer match play induces substantial mechanical, metabolic, inflammatory, and neuromuscular stress, yet post-match monitoring in applied settings often relies on isolated markers, venous sampling, or limited time points. This observational repeated-measures study aimed to describe whether capillary-derived biomarkers, neuromuscular performance, and perceptual measures showed asynchronous recovery during the first 48 h after a standardised soccer match in elite players. Methods: Twenty-two elite male outfield soccer players completed a standardised 90 min match. Capillary blood biomarkers, countermovement jump (CMJ), 20 m sprint performance, maximal voluntary contraction (MVC), and delayed onset muscle soreness (DOMS) were assessed before the match, immediately post-match, and at 24 and 48 h post-match. Time effects were analysed using repeated-measures mixed-effects models, and associations between biochemical and functional responses were examined descriptively. Results: Match play induced clear but domain-specific disturbances. IL-6 and cortisol rose rapidly immediately post-match, whereas hsCRP, CK, LDH, myoglobin, and DOMS showed delayed peaks during early recovery. CK, LDH, myoglobin, and soreness remained above baseline at 48 h. CMJ and sprint performance were impaired after the match but largely recovered by 48 h, whereas MVC showed its greatest decrement at 24 h. Exploratory associations indicated that larger muscle damage responses tended to co-occur with greater strength and jump decrements and higher soreness, but these analyses were not causal. Conclusions: Recovery after a standardised elite soccer match was multidimensional and non-synchronous across physiological, neuromuscular, and perceptual domains. A capillary-based, multi-domain assessment strategy may provide a feasible descriptive perspective for field-based observation of post-match fatigue.
- 29 May 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (6) , 370
Open AccessAcute Capillary Plasma Biomarker, Neuromuscular, and Perceptual Responses to Standardised Soccer Match Play in Elite Players: A Descriptive Study of Asynchronous Multi-Domain Recovery
Background: Soccer match play induces substantial mechanical, metabolic, inflammatory, and neuromuscular stress, yet post-match monitoring in applied settings often relies on isolated markers, venous sampling, or limited time points. This observational repeated-measures study aimed to describe whether capillary-derived biomarkers, neuromuscular performance, and perceptual measures showed asynchronous recovery during the first 48 h after a standardised soccer match in elite players. Methods: Twenty-two elite male outfield soccer players completed a standardised 90 min match. Capillary blood biomarkers, countermovement jump (CMJ), 20 m sprint performance, maximal voluntary contraction (MVC), and delayed onset muscle soreness (DOMS) were assessed before the match, immediately post-match, and at 24 and 48 h post-match. Time effects were analysed using repeated-measures mixed-effects models, and associations between biochemical and functional responses were examined descriptively. Results: Match play induced clear but domain-specific disturbances. IL-6 and cortisol rose rapidly immediately post-match, whereas hsCRP, CK, LDH, myoglobin, and DOMS showed delayed peaks during early recovery. CK, LDH, myoglobin, and soreness remained above baseline at 48 h. CMJ and sprint performance were impaired after the match but largely recovered by 48 h, whereas MVC showed its greatest decrement at 24 h. Exploratory associations indicated that larger muscle damage responses tended to co-occur with greater strength and jump decrements and higher soreness, but these analyses were not causal. Conclusions: Recovery after a standardised elite soccer match was multidimensional and non-synchronous across physiological, neuromuscular, and perceptual domains. A capillary-based, multi-domain assessment strategy may provide a feasible descriptive perspective for field-based observation of post-match fatigue.
- Open Access
The Effects of Astaxanthin Supplementation on Exercise Recovery Biomarkers and Exercise Performance: A Systematic Review and Meta-Analysis
Background: Astaxanthin is a lipid-soluble carotenoid with antioxidant and anti-inflammatory properties, but its effects on exercise performance and post-exercise recovery remain uncertain. This systematic review and meta-analysis aimed to evaluate the effects of astaxanthin supplementation on exercise performance and recovery-related biomarkers in healthy participants and athletes. Methods: This review followed PRISMA 2020 guidelines. PubMed, Web of Science, Embase, EBSCO, the Cochrane Library, and CNKI were searched from inception to January 2026. Randomized controlled trials comparing oral astaxanthin supplementation with placebo or control were included. Performance outcomes included VO2max, time-trial or endurance-related performance, and maximal workload or power output. Recovery-related outcomes included creatine kinase, lactate dehydrogenase, malondialdehyde, interleukin-6, and related biomarkers. Standardized mean differences with 95% confidence intervals were pooled. Results: Twenty-four RCTs were included. Astaxanthin significantly reduced creatine kinase levels (SMD = −0.45, 95% CI: −0.83 to −0.07). Lactate dehydrogenase also favored astaxanthin (SMD = −0.93, 95% CI: −1.39 to −0.48), although heterogeneity was substantial. No significant effects were observed for malondialdehyde or interleukin-6. Astaxanthin did not significantly improve VO2max, time-trial performance, or maximal workload/power output. Conclusions: Current evidence suggests that astaxanthin may be more beneficial for post-exercise recovery than for direct performance enhancement. The most consistent effect was observed for creatine kinase, whereas the LDH finding should be interpreted cautiously. Further well-powered trials with standardized dosing, duration, exercise protocols, and outcome assessments are needed.
Open AccessThe Effects of Astaxanthin Supplementation on Exercise Recovery Biomarkers and Exercise Performance: A Systematic Review and Meta-Analysis
Background: Astaxanthin is a lipid-soluble carotenoid with antioxidant and anti-inflammatory properties, but its effects on exercise performance and post-exercise recovery remain uncertain. This systematic review and meta-analysis aimed to evaluate the effects of astaxanthin supplementation on exercise performance and recovery-related biomarkers in healthy participants and athletes. Methods: This review followed PRISMA 2020 guidelines. PubMed, Web of Science, Embase, EBSCO, the Cochrane Library, and CNKI were searched from inception to January 2026. Randomized controlled trials comparing oral astaxanthin supplementation with placebo or control were included. Performance outcomes included VO2max, time-trial or endurance-related performance, and maximal workload or power output. Recovery-related outcomes included creatine kinase, lactate dehydrogenase, malondialdehyde, interleukin-6, and related biomarkers. Standardized mean differences with 95% confidence intervals were pooled. Results: Twenty-four RCTs were included. Astaxanthin significantly reduced creatine kinase levels (SMD = −0.45, 95% CI: −0.83 to −0.07). Lactate dehydrogenase also favored astaxanthin (SMD = −0.93, 95% CI: −1.39 to −0.48), although heterogeneity was substantial. No significant effects were observed for malondialdehyde or interleukin-6. Astaxanthin did not significantly improve VO2max, time-trial performance, or maximal workload/power output. Conclusions: Current evidence suggests that astaxanthin may be more beneficial for post-exercise recovery than for direct performance enhancement. The most consistent effect was observed for creatine kinase, whereas the LDH finding should be interpreted cautiously. Further well-powered trials with standardized dosing, duration, exercise protocols, and outcome assessments are needed.
- Open Access
The Effects of Seaweed and Microalgae Supplementation on Exercise Performance and Recovery: A Systematic Review and Meta-Analysis
Objective: Seaweed and microalgae provide antioxidants, polyunsaturated fatty acids, and bioactive compounds that may enhance exercise performance and accelerate recovery. However, evidence remains inconsistent. This systematic review and meta-analysis aimed to evaluate the effects of algae-derived supplementation on exercise performance and physiological recovery outcomes in healthy and athletic adults. Methods: This review was registered in PROSPERO (CRD420251166723) and conducted in accordance with PRISMA 2020 guidelines. PubMed, Web of Science, Embase, Cochrane Library, EBSCO, and CNKI were systematically searched for randomized controlled trials (RCTs) evaluating algae supplementation in exercise contexts. Inclusion and exclusion criteria were defined based on the PICOS framework. Primary outcomes included VO2max, Time to exhaustion (TTE), maximal power output (WRmax), Time-Trial (TT) performance, and creatine kinase (CK). Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup, sensitivity, and publication bias analyses were performed. Results: Twenty-two RCTs (n = 822) investigating Spirulina, Chlorella, brown-algal polysaccharides, or astaxanthin met inclusion criteria. Algae supplementation showed a suggestive improvement in VO2max (SMD = 0.88, 95% CI: 0.00–1.75) and significantly improved in TTE (SMD = 1.06, 95% CI: 0.16–1.96), with smaller effects on WRmax (SMD = 0.29, 95% CI: 0.03–0.55), and no significant benefit for TT performance (SMD = −0.27, 95% CI: −0.74 to 0.21). Regarding recovery, CK concentrations were significantly reduced (SMD = −0.78, 95% CI: −1.28 to −0.28). Subgroup analysis suggested greater effects for Chlorella supplementation, higher dosages, and aerobic training contexts; reductions in muscle-damage markers were more evident following resistance exercise. Sensitivity analyses supported the robustness of the main findings with minimal evidence of publication bias. Conclusions: Algae-derived supplements—particularly Spirulina and Chlorella—may modestly enhance aerobic exercise performance and attenuate exercise-induced muscle damage under certain conditions. Effects appear to depend on algae species, dosing strategies, intervention duration, and training modality. High-quality, multi-center RCTs incorporating mechanistic endpoints are needed to clarify optimal application and to develop athlete-specific recommendations.
Open AccessThe Effects of Seaweed and Microalgae Supplementation on Exercise Performance and Recovery: A Systematic Review and Meta-Analysis
Objective: Seaweed and microalgae provide antioxidants, polyunsaturated fatty acids, and bioactive compounds that may enhance exercise performance and accelerate recovery. However, evidence remains inconsistent. This systematic review and meta-analysis aimed to evaluate the effects of algae-derived supplementation on exercise performance and physiological recovery outcomes in healthy and athletic adults. Methods: This review was registered in PROSPERO (CRD420251166723) and conducted in accordance with PRISMA 2020 guidelines. PubMed, Web of Science, Embase, Cochrane Library, EBSCO, and CNKI were systematically searched for randomized controlled trials (RCTs) evaluating algae supplementation in exercise contexts. Inclusion and exclusion criteria were defined based on the PICOS framework. Primary outcomes included VO2max, Time to exhaustion (TTE), maximal power output (WRmax), Time-Trial (TT) performance, and creatine kinase (CK). Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup, sensitivity, and publication bias analyses were performed. Results: Twenty-two RCTs (n = 822) investigating Spirulina, Chlorella, brown-algal polysaccharides, or astaxanthin met inclusion criteria. Algae supplementation showed a suggestive improvement in VO2max (SMD = 0.88, 95% CI: 0.00–1.75) and significantly improved in TTE (SMD = 1.06, 95% CI: 0.16–1.96), with smaller effects on WRmax (SMD = 0.29, 95% CI: 0.03–0.55), and no significant benefit for TT performance (SMD = −0.27, 95% CI: −0.74 to 0.21). Regarding recovery, CK concentrations were significantly reduced (SMD = −0.78, 95% CI: −1.28 to −0.28). Subgroup analysis suggested greater effects for Chlorella supplementation, higher dosages, and aerobic training contexts; reductions in muscle-damage markers were more evident following resistance exercise. Sensitivity analyses supported the robustness of the main findings with minimal evidence of publication bias. Conclusions: Algae-derived supplements—particularly Spirulina and Chlorella—may modestly enhance aerobic exercise performance and attenuate exercise-induced muscle damage under certain conditions. Effects appear to depend on algae species, dosing strategies, intervention duration, and training modality. High-quality, multi-center RCTs incorporating mechanistic endpoints are needed to clarify optimal application and to develop athlete-specific recommendations.